Wall Street Zen Downgrades American Well to Sell Rating

Analysts cite concerns over the telehealth company's future performance

Mar. 14, 2026 at 6:40am

Got story updates? Submit your updates here. ›

Investment research firm Wall Street Zen has downgraded American Well (NYSE:AMWL) from a "hold" rating to a "sell" rating in a new research report. The analysts cited concerns over the company's future performance and lowered their price target on the stock.

Why it matters

American Well is one of the leading telehealth platforms, providing virtual care services to healthcare providers, payers, employers, and patients. The downgrade from Wall Street Zen reflects growing skepticism about the company's ability to maintain its market position and profitability in the increasingly competitive telehealth space.

The details

In their research note, Wall Street Zen analysts lowered their price target on American Well from $10.50 to $6.00 and assigned a "sell" rating to the stock. This follows previous price target reductions from other firms like Morgan Stanley and Stifel Nicolaus. The analysts believe American Well is facing headwinds that could impact its future financial performance.

  • American Well stock closed at $5.67 on Friday, March 13, 2026.

The players

Wall Street Zen

An investment research firm that provides analysis and ratings on publicly traded companies.

American Well

A Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers, and patients.

Got photos? Submit your photos here. ›

The takeaway

The downgrade of American Well by Wall Street Zen highlights the increasing challenges facing telehealth companies as the market becomes more crowded and competitive. Investors will be closely watching to see if American Well can maintain its market position and profitability in the face of these headwinds.